The president’s executive order instructs HHS to ensure people on commercial ins...
A new vaccine could increase the number of children around the world who are pro...
Frictionless cancer screening? Color Health, a health tech company known for its...
At a defunct power station, the U.K. and Moderna celebrate a partnership meant t...
Privately insured families pay on average about $3,000 for maternal and newborn ...
“It's very motivating to me to actually provide the evidence to show the benefit...
If 50 years ago the field of OB-GYN had not been so skittish about abortion, thi...
The FDA has blocked the approval of Intercept’s NASH therapy, pushing the compan...
IRBM has extended its collaboration with MSD to develop peptide therapeutics, fo...
Sarepta will now need to complete a confirmatory trial to prove the therapy impr...
NephroDI Therapeutics has signed a deal with the McQuade Center for Strategic Re...
Facilities in Andhra Pradesh and Telangana accounted for 23% of all sites in Ind...
The regulatory framework governing medicine development is in flux. CDMOs face g...
Erasca has obtained orphan drug designation (ODD) from the US FDA for ERAS-801 t...
Talaris Therapeutics has entered into a definitive agreement to merge with late-...
Kymera Therapeutics has announced that the FDA has granted KT-253 orphan drug de...
